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Interview by RHM Assistant Editor Cathryn Molloy, Ph.D. Editing by RHM Assistant Editor Erin Trauth, Ph.D. 
C. Molloy: 00:00 Hi everyone. Today, in my capacity as one of the assistant 
editors for the Rhetoric of Health and Medicine journal, I have 
the pleasure of talking with authors Liz Angeli and Christina 
Norwood about their piece that was published in the very first 
public health special issue of the journal. And their piece was a 
persuasion brief titled The Internal Rhetorical Work of a Public 
Health Crisis Response. So welcome Liz and Christina. 
L. Angeli: 00:25 Great, thank you. 
C. Molloy: 00:28 Of course. I just wondered if you both could just introduce 
yourselves to the audience if you don't mind. 
L. Angeli: 00:36 Sure. Hi, I'm Liz Angeli. I'm an assistant professor at Marquette 
University where I teach and study technical communication 
and the rhetoric of health and medicine. 
C. Molloy: 00:46 Excellent. 
C. Norwood: 00:48 And I am Christina Norwood.I was an understudy of Liz at 
Towson University. Now I am a technical writer and editor at 
the National Cancer Institute where I do a lot of work with 
patient content related to cancer and cancer treatment. 
C. Molloy: 01:05 Excellent. Well, thank you both again for taking the time to do 
this interview. Your piece, your persuasion brief, is great. And so 
I'm really interested to learn more about your process and for 
you to tease out some of these concepts that you, these rich 
concepts that you worked at from your data. So the first 
question I have for you: is your persuasion brief shows how a 
rhetorical concept, specifically techne, allows you to name and 
parse and thus illuminate a set of complex communicative 
processes in public health that are under-described or under- 
theorized. Could you say a bit more about how the specific 
theories of techne you were drawing on in your analysis allow 
you to theorize what you called "gut feeling?" 
L. Angeli: 01:48 Yeah, so looking at techne, I'm not going to lie, it was a little 
intimidating because there are so many different theories out 
there and we really went back and forth of is this techne or is 
this phronesis and what's, what's the, the dividing line between 
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the two. And you know, I mean, I'm going to kind of go out on a 
limb here and be a little bit vulnerable. It can be really 
intimidating writing about theory; when Christina and I really, 
this is one reason why we work so well together: we really live 
in that theory-practice balance. And so, you know, when we're 
like, okay, well there's something going on here with you know, 
rhetorical concepts, you know, what are we gonna...what are 
we going to take up? And techne seemed to be the best fit 
because it was capacious yet it was structured enough to let us, 
you know, talk about what we saw happening in our in our data 
with our transcripts in the written information that we're 
collecting from the Johns Hopkins Medicine Ebola Crisis 
Communications Team. 
L. Angeli: 02:51 It's such a long name so I think we might be referring to it as the 
ECCT when we, when we go forward because it's helpful. So we 
were able to look at these these particular aspects of techne, 
focusing on the idea of habituated expertise and experience 
because that's what we really saw the team referring to when 
they were trying to revise these protective or personal 
protective equipment guidelines. You know, the two people we 
sat down with, they kept saying, you know, we have a lot of 
expertise in the field, the people on our team have a lot of 
expertise in the field, and the user experience, we used gut 
feelings, and they really focused a lot on limitations. And so, you 
know, those are all aspects of techne. We really relied mostly on 
a Janice Lauer's work with techne and a Janet Atwell's stuff too, 
just because it seemed to align well. It aligns the most with this, 
this public health crisis communication that we really yeah, that 
we're working with this. 
C. Norwood: 03:55 Yeah. And just after that, you know, just talking about medicine 
or the practice of medicine sort of lends itself nicely to fit a sort 
of theory because it sort of also meets all of the different 
qualifications. So it seemed like techne was a natural fit to 
discuss, you know, something like a practice communication 
especially in the, the healthcare and medical center. 
C. Molloy: 04:18 I completely agree with that. Christina. And I had for, just for 
both of you, I think techne was absolutely the right choice. And, 
I agree, Liz and I think that's great that you said that because for 
people who are maybe thinking about writing from a theoretical 
perspective, maybe they would feel more invited in to do it by 
having great models like your work, but also learning like, oh, 
even these scholars and practitioners, writers who are 
incredibly smart, they too feel like it can be intimidating. But I 
think the fact that you're trying to describe an under-described, 
under theorized, I think that it's too easy to say that person, 
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that particular team, they just did a good job-- who knows why. 
And you're trying to extract some kind of technique so that 
other people could. And you did this beautiful heuristic. And so I 
think techne was absolutely a great choice. And I think that you 
articulated that well. 
L. Angeli: 05:07 And to add onto that too. This is another reason I always, I love 
working with Christina and just we'll provide some background 
later. But like Christina mentioned, when I was a Towson 
University from 2012 to 2016 she was in our master's of 
professional writing program. And that's how we started 
working together. And you know, it was so nice as we were 
going through this. It was knowing that we were writing a 
persuasion brief that is intended to be written by practitioners. 
You know, you want to use theory that can be easily explained 
and easily understood by people who are doing this every single 
day. And really, I mean, this is not an overstatement, trying to 
save people's lives. I mean, when it came to the Ebola crisis well 
all remember how scary that was. And the level of lethality of 
Ebola is pretty intense. And so it was, yeah, it was just 
important to us to make sure that we weren't trying to grapple 
with something that we could not explain in a persuasion brief. 
C. Molloy: 06:07 Absolutely. And I think that is really important. That's the 
purpose of this genre. And if you, if you're doing it well, you 
want to be it to be something you can hand to practitioners and 
it will, I think it will not feel like it's esoteric or academic 
nonsense. And so, but I, that's what is so beautiful about what 
you do. The way that you used it in your piece is that you are 
using a dense, complex rhetorical concept and yet making it like 
a totally logical thing in the way that it's used and also offering 
very clear takeaway from it too. So, I think that's really great. 
Cool. So, the next question I have for you two is I really 
appreciated your emphasis, especially on the complexity of the 
rhetorical situation and the communicative tasks at hand during 
the early days of the Ebola crisis. You really recreate that well in 
the text; you successfully emphasize the need for timely, 
effective communications with multiple stakeholders and with a 
variety of purposes. What is striking about this case is that it 
resists over-simplified approaches to invention. So, I love the 
idea of offering this heuristic that I mentioned already that 
takes, that you, you developed and takes stock of how and why 
the case you examined was successful such that future health 
communicators might benefit. How might this piece also be 
useful in classrooms, do you think? 
C. Norwood: 07:28 Well, I mean I think, I think what's special about this piece is 
that we were, you know, we initially had met, it sort of started 
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in the classroom as a real world example, something that was 
unfolding in real time and at the time, you know, in 2014, there 
were some unknowns, and so it was just, it was just a very 
interesting way to sort of discuss failure in the classroom and 
sort of theories around that. And so it's very helpful. I think that 
just having a case study where you can sort of follow it in 
modern time from start to finish, is very helpful and relevant, 
for someone who is, who has a role, you know, has a role and 
actually and, you know, similar topics as a professional. So, you 
know, I just thought there was tremendous value in it. 
C. Norwood: 08:22 It was , it was an awesome learning experience. Like Liz 
mentioned earlier as well, we were both able to lend our 
experience, you know, as rhetoricians and then coming from a 
healthcare background. And so that really was helpful. We 
were, we were looking at these things that I had experienced, 
for example, with the um, PE documenting. I, you know, as an 
undergrad and I was working in the hospital as an IB pharmacy 
technician. I prepared chemotherapy, things like that. So I 
routinely had to put these things on, you know, and so just 
having that perspective on it, it got, you know, explaining a little 
bit about, is this if this right? Does this makes sense? You know, 
what, and then we started looking into, you know, what was 
their rationale for choosing this PPE versus another one. 
C. Molloy: 09:18 Huh. Interesting. 
C. Norwood: 09:20 So, yeah, so I mean, whenever there's something that's real-
world happening, I think it's the right time to, you know, try to 
capture that in the classroom. 
C. Molloy: 09:29 Right. That's great. So then it's almost like kairos-driven. It's this, 
this thing is actually happening. There's this really well-rounded 
case study. It has some links to what students know about and 
do outside the classroom. That's brilliant. That's really good. 
L. Angeli: 09:44 To kind of go back to the oversimplification, the one thing and 
the beauty of Towson's -- I'm going to do a kind of a plug -- the 
beauty of Towson's master's program is that most of the 
students, I mean I don't think it's changed that much since I've 
been there in a few years, but they're just like Christina, they 
are working during the day, usually for some type of 
government agency and then they come to class at night and 
you know, we would, I would bring in, you know, the PPE. It's, 
it's super easy to be critical -- a Monday morning quarterback -- 
of, you know, I believe the CDC should have done this and blah, 
blah, blah. We pushed back against that and drawing on all of 
the, like Christina said, the knowledge that we had in the, in the 
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classroom, you know, Christina's knowledge in healthcare. My 
knowledge of, you know, being a healthcare provider. 
L. Angeli: 10:31 We thought, okay, there's something going on here. It's not that 
easy. And so, and because we were, when Christina were 
preparing for this interview, you know, we were probably, oh 
yeah, I think I had heard on the local NPR station or something 
that Hopkins was being and was involved in the revision of the 
CDC's PPE and brought it to class that night and speaking to 
kairos. And remember we're in the same city as Hopkins. I had a 
former student who now works at Hopkins, so why don't we do 
something about it? And Christina was super. I can still 
remember the energy in the room that night when we talked 
about this. And you know, this is going on five years ago now. 
This sort of, you know, let's look into this. Let's not just sit in the 
classroom and talk about and criticize, let's get to the bottom, 
investigate what's going on behind the scenes because it's never 
as easy as it looks. 
C. Molloy: 11:32 I think you're completely, I mean, I think that that is a real 
challenge. And that's what I like about RHM and being at the 
intersection of the, of the sort of the hard sciences, the social 
sciences, the humanities, because certainly from some like real 
high up in the humanities spaces ideologically, it seems like all 
you really do if you're looking at something from the outside is 
say, well this is everything they did wrong and not really having 
any empathy for working professionals and that this is their day 
to day life and this is them doing their best and they're not like 
setting out to do harm or anything. And so I think that is, that is 
definitely the viewpoint that you all sort of espouse in your 
piece and that's made it really good. 
C. Norwood: 12:18 I was just going to say to that point, and you probably might be 
about to say something similar, is that there's also something to 
be learned from failure, you know you know, and the CDC and 
the, you know, rest of the infectious disease community as well 
as everyone who was, you know, involved in any, you know, any 
sort of kind of general way, also learned a lot from this 
experience. So, you know, that's also the interesting thing about 
this is that we're sort of documenting failure and then correct. 
You know, and part of that what was happening in the 
classroom is that sort of gut feeling thing, you know, like there 
seems like there's more to this, you know, from my experience 
you've got to think, my reaction was for my experience in 
preparing, you know, IB, I wouldn't feel comfortable. Like I 
know like all the areas that are, I wouldn't feel comfortable with 
that. So it was like, why, why did they see that? And you know, 
5
Molloy and Trauth: RHM Author Interview: Liz Angeli, Ph.D. and Christina Norwood, M.S.
Published by STARS, 2019
we'll probably get into why they chose that later, you know, and 
I was stressing, but it's just, just a fascinating topic for me. 
C. Molloy: 13:29 Yeah. I love how you said that. I mean that's great Christina. 
Absolutely. All the things that can be learned from failure and 
the, and the course correction that follows. That's great. 
L. Angeli: 13:39 The only part I was going to add onto that and just, you know, 
Christina bringing up the gut feeling part, this, this isn't 
something that we really wrote about, but you know, just the, 
the classroom experience of faculty, you know, master's, grad 
student co-authoring. Cause I think so often we, and this might 
be an, this might be an oversimplification, but you know, it's 
usually the doctoral students co-authoring with, with faculty 
and you know, Towson's master's programs. It's, it's a terminal 
program. There is no PhD at Towson. And so it was such a great 
experience, you know, and I might just make it for myself. I 
don't want to put words in your mouth. 
L. Angeli: 14:24 It's been, it's been so fun. I mean I've learned so much from 
Christina, you know, she's, she'll push back and go, you know 
what, when we're analyzing that data, I'm not seeing this the 
same way as you are saying. Okay, you're the one who's going 
to the NIH every day. Let's figure out what's going on. You 
know, drawing on your, your expertise as a tech writer. Um, you 
know, just to, I don't know, just get to get those different 
perspectives. And I think, you know, Christina was saying we 
sort of were enacting what the, the Ebola Crisis 
Communications Team was doing, too, you know, trusting each 
other, letting each other take the lead in certain cases. You 
know, when we, we presented at two or three conferences. At 
least. I can't remember, I think it was two or three. We've got 
two publications out of it now. Um, and now that, you know, 
we're in two different cities, this still connects us, you know, I 
mean it's just great. 
C. Molloy: 15:23 No, it's, it's really great, I mean, it's great and I do think that it's, 
it's so different than you, if you were to collaborate with a 
doctoral student who's also going the academic route versus 
someone who has a clear practitioner role and lots of expertise 
that academics don't. And so I bet Christina was the ideal 
collaborator and like you said, a chance to extend that 
relationship beyond the classroom. 
L. Angeli: 15:49 Yeah. 
C. Norwood: 15:50 Yeah. I mean, I, yeah, I don't want to linger too much on this 
question, but I have to say that I agree with Liz about the 
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experience. It was, it was very neat. You know, I came in as a, as 
a tech writer already into the master's program, fairly far into 
my career, but I had been, too, behind the scenes. So to do 
things like that, conferences and you know, sit on panels, was 
very new and kind of scary to me. And it was like having lived 
that before you know, just sort of gives me the confidence to do 
that. And so once you do that, then you're like, oh well I can do 
this and you know, and that sort of advises you and gives you 
confidence to do other things. So I think that just having that 
experience they were willing to sort of go out of comfort zone 
knowing, you know, this is something that they're terrified of 
but you're going to do in anyway. 
C. Norwood: 16:46 That in and of itself, is there something that I, you know, 
probably that I didn't want to say coming out of it. And so that's, 
that's also wonderful, um, [inaudible] in the paper. Um, and so 
I, I just really appreciate that part of it. And prior to that we 
needed to you know, partner with her and do all the things. I 
learned so much and I think that, you know, at this point, I feel 
like I'm more senior level in my career. But the thing is I wanted 
to always have a mentor and to be a mentor to those things. At 
the same time, you know, I always I to, you know, always tried 
to do that as a professional. And you just learn so much. You 
learn so much from teaching and you learn so much from 
someone who's willing to share, you know, so, you know, 
there's so much like outside of the, the things that we produce, 
you know, there were so many other things that changed from 
this, but I'm really grateful. Yeah. 
C. Molloy: 17:50 That is great. I'm glad actually that you added this to the 
conversation because some people might be thinking, okay, if 
Christina is not going the academic route, then beyond maybe 
the feather in your cap of publication, what it is that are you 
getting? And you articulated that really, really nicely that 
actually these experiences have built your confidence and, and 
that's going to manifest itself in a whole variety of ways as you 
continue to build your already pretty-established career. So 
that's really great. So, okay, so the next question that I have for 
you is your candor, I thought, on the process of data collection 
was very refreshing. You know, that your calls and emails went 
unanswered. I feel like these are the kinds of research stories 
we don't hear enough. So when you were attempting to include 
leading patients, even safety experts in your study, they just 
weren't getting back to you. So I just wondered, since you were 
brave to share this, and I thought refreshingly so, what advice 
do you have for other researchers who are hitting roadblocks in 
data collection? And I'm thinking in particular of early-stage 
research researchers that are like, well, they didn't get back to 
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me. So the project's over, right, like you come across this. So I 
thought maybe it would be great for people to hear more from 
the two of you about how you kind of stayed the course, right, 
beyond these roadblocks. 
L. Angeli: 19:06 It happens all the time, you know, I mean it does, it's not even 
just to think in, in, you know, academic research. But I mean 
sometimes people aren't going to get back to you for whatever 
reason. And it's easy to take it personally, but it's not personal, 
you know? I mean, or I'm sure most of the time it isn't. I mean, 
the person who we were trying to contact is a very prominent 
figure. And you know, I, you know, and the people, people in 
RHM and people who work in the medical field know that 
physicians are very busy people and wear a lot of hats. And you 
know, we were grateful that Dr. Maragakis even got back to us. 
I was like, Oh, okay, great. You know, this is, this is good. And 
then you know, Mr. Butanis, then got back to us too. But you 
know, we tried I think three times. 
L. Angeli: 20:01 That's usually what I do is if I'm not hearing back after about 
three attempts and waiting about five to seven business days. 
And you know, Christina was obviously in on the decision 
making with this too, cause it wasn't just, you know, I wasn't 
just gonna make the decision myself to just let it go. You know, 
we were like, okay, this door might be closing for a reason. Let's 
not try to pry it open. You know, it's, let's see what else we can 
do. And the beautiful thing about this particular project is that 
there was a ton written out there about what Hopkins was 
doing with CDC and PPE. And so, you know, we combed the 
internet and just, we're looking for press releases and news 
releases and searching in common through social media. And 
Ben Butanis helped us with that to try to out, you know, where 
to go and how to tell the, the chronology of everything, which 
was... 
C. Molloy: 20:53 Uh, huh... 
L. Angeli: 20:53 ...Pretty Difficult. I mean, that was the one thing, Christina she, 
she pays so such attention to detail. There'd be, sometimes it'd 
be writing drafts and she'd say this happened before this 
happened. Alright. Change it, change it. You know, cause it just, 
cause we just had so much information we were getting and 
you know, there came a point where I think a lot of times... 
L. Angeli: 21:14 ...You Never think you're going to have enough data and two 
interviews can get you enough data. And if you've got, you 
know, a bunch of textual stuff to, you know, talk about, I mean 
yeah, we have gotten, I was just remembering we have gotten 
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three conference presentations out of this and the two and the 
two publications and they're different enough to be two 
different things. So it was a, I dunno, but it's I would encourage 
people to, to be vulnerable and write about these roadblocks. 
Obviously, as you can tell, Christina and I are pretty candid. I 
mean, right. 
C. Molloy: 21:50 In a way that's going to help other people, and I know Lisa and 
Blake are working on these ethical exposures essays that were 
due I think at the end of August. So hopefully there will be, I 
know that one of their agendas is to have more content in the 
journal that speaks explicitly to problems and issues and 
methodologies as well as like tactics for overcoming. But I did 
notice, I thought, wow, this is great. Because I think a lot of 
times when in the write up people want to like tell the story 
about just the blow by blow of this is were, these were my 
methods. And maybe in a footnote you might see here's 
something that didn't go well. But I loved that, that right in the 
body of the essay it says these, these calls and emails went 
unanswered and, and on we went. So this is this is, I think, great 
advice for other researchers that there is other data out there 
and there are a lot of riches in even two interviews. So I think 
that's great. 
C. Norwood: 22:40 Yeah, it is. It' seemed appropriate for the topic, you know, just 
saying, you know, in the context that we'll be writing about and 
the only information that was available, it just seemed 
appropriate to, you know, openly acknowledge, you know, that 
we encountered that. And I also just wanted to mention like, 
you know, the people that we were able to interview were very, 
very qualified. So Dr. Maragakis, for example, he was the senior 
director for healthcare epidemiology and infection for Hopkins. 
And she works for that, um, the public health arm of, you know, 
of Hopkins. So, you know, she was, she was very it was very nice 
to have her ear and she was very open with information and 
giving background and contacts and things like that. And she 
had a direct role in this process. So, you know we didn't get 
everyone that we wanted, but you know, I think we had 
certainly ended up knowing that we felt like we had something 
that has worked well here. Ben Butanis, um I think he was like 
the communication lead for marketing. So he also had his role in 
this process. So, um, we definitely still considered the glass half 
full, um, with who we were able to get. 
C. Molloy: 24:02 I think that's really important to point out that these were 
pretty heavy hitters that you were able to speak with. So it's not 
like you took like Team B or something like that. 
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L. Angeli: 24:12 And just to add, and I realized that I've pronounced Dr. 
Maragakis' name wrong. I remembered the Mara part. Um, but 
uh, what she, because as Christina said, she is so prominent, she 
had publications out about this by the time we were getting 
ready to write and because you know, medicine and science just 
goes, goes, goes. And so she had publicly available slide decks 
that we were pulling from. And so I think that's another piece of 
advice that I share with people is if you're interviewing these big 
heavy hitters like Dr. Maragakis. Um, you go, you know, look at, 
look them up in databases, Google Scholar them. Um, you'll, 
you'll find stuff and kind of, you know, speaking to Lisa and 
Blake, because I know they've got, and this is going to be a 
shameless plug, I wasn't sure if I was going to do this, but I'm 
doing it. In Lisa and Blake's Methodologies for the Rhetoric of 
Health and Medicine. My chapter in there is all about 
overcoming roadblocks in research projects. And I drew on a lot 
of that trying to figure out, um, okay, so if this interview is not 
going to come through, what are the other venues and avenues 
that we can get to kind of triangulate some of this stuff? Or if an 
email isn't working, maybe we should try a phone call or maybe 
there's a different admin assistant who we can contact or 
maybe, you know, Mr. Butanis, Ben could try to get us in with 
someone. 
C. Molloy: 25:38 Okay, that's great. So if for people who are looking for real, 
tangible strategies, that chapter is a good resource also. Yeah, I 
want to read it. So I'm making my way through that collection. 
It's like a little dessert to other readings, you know, when you're 
doing lots of other, oh, I'm going to read one of these chapters. 
So it'll be next on my list. Okay. So the next question I have for 
the two of you is: an intriguing part of your heuristic and your 
analysis leads up to, is the emphasis on "considering failure 
points and limitations as an important step" to "finding avenues 
around them" What other applications might, might such an 
approach have in related health and medical situations? Giant 
question. So even if you just take a little slice of it, that's great. 
C. Norwood: 26:23 Sure. So I guess we're asking, I mean it has pretty much all of 
health and medicine for the most part. I mean any, I mean, and 
it doesn't necessarily even have to be a crisis per se, but if we 
say all the area of practice, I'm thinking, you know, a natural 
disaster, you know, sort of, you know, anything bio-terrorism, 
you know, out of the health sector a little bit, cause it's like a 
marketing crisis that's happening quite frequently. Some sort of, 
you know, financial crisis. So yeah, there are so many 
applications where, you know, the steps they took to sort of 
mitigate it would still be relevant. If there's something for 
technical communicators to learn from. So, you know, I guess if 
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we're thinking about, you know, where it can apply, I mean, I 
use, you know, some of the heuristics that we worked on and 
refined in the paper and, it works, you know, and I, you know, 
it's not necessarily that I'm always writing about a crisis, but I do 
write and edit content about cancer and cancer treatment. And 
then they're like, you know, difficult things to talk about, like 
prognosis you know, when treatment isn't available and you 
know, those kinds of things. So whenever you're writing with 
the intent or something like that, it depends on what you're 
writing upon. I think that this happens. 
C. Molloy: 27:56 Well, that's great. Christina, you're, you're pointing out that this 
has lots of applications even in your position. And, and that it 
doesn't always need to be something that's a crisis situation for 
that, that focus on failure points and limitations and with 
avenues around that. That's great. That's really good. 
L. Angeli: 28:12 That something, because when Christina and I were preparing 
for this, you know, we talked about how a lot of the sciences 
and all the medicine's all about data, and as we know, you 
know, data is more than numbers. I mean, your body gives you 
data when you're in meetings and you know, if you're going like 
this about something that's going on, it's just, okay, what is, 
what's your body telling you? Are you anxious about 
something? Are you feeling insecure and threatened? Why 
might you be feeling like that? Is there a failure that you're 
coming up against and there's fear that's underneath that and 
just, you know, having the kind of the confidence to break those 
open a little bit. And one of the things that we were hoping with 
the heuristics that, you know, people use it, okay, this isn't a 
published peer reviewed journal article. 
L. Angeli: 29:01 It's got some, you know, ethos behind it. Just to kind of pull that 
out. And, you know, in a lot of the stuff that we're talking about, 
you know, as I was just thinking about the heuristics and 
everything's really grounded in, you know, slowing down, not 
reacting, not reacting. I mean, sometimes you have to, but you 
know, that was really what the ECCT did at Hopkins, was they, 
they were quick, quick reaction. It was, okay, let's, let's take our 
time a little bit. I mean, they didn't have a lot of time, but you 
know, sometimes just pausing for 30 seconds just to do a check-
in about, you know, okay, so so-and-so's got expertise in this 
field maybe I don't have as much in that field. So now it's my 
turn to just listen and let someone else step up. And if I have 
issues with that, I gotta deal with it, you know, I mean, so it's 
just, I don't know. 
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L. Angeli: 29:52 I do think there's a lot of value in just the whole concept of 
throwing, not throwing down, and slowing down. That's a whole 
different thing. But just yeah, and I, that's another reason why, 
you know, collaborating with Christina was so great is because 
we were, we were teasing these heuristics out. She would say, 
you know, I feel like I could do this in a meeting or I actually did 
this yesterday, you know, here's another question we might 
want to add then, you know. So that was, I mean, even in 
faculty positions, I think we can, we definitely can use these 
heuristics too cause they apply to much more than just you 
know, the practice of medicine and healthcare. 
C. Molloy: 30:37 Absolutely. 
C. Norwood: 30:41 It was very interesting to hear Dr. Maragakis go through this 
whole part, you know, about the considering failures and 
limitations. I mean, this was one of the impetus to why often 
sort of step out on a limb and did some things, something 
different from what she was recommending. That was pretty 
controversial at the time. And it was that whole thing of you 
have to do what you're asking your reader or your, you know, 
your audience to do. And so she actually, she and her team of 
nurses, you know, physicians all the, you know, the personnel, 
they went through the process of doing what the CDC said and 
they came to the conclusion that this doesn't feel right. You 
know, like, you know, this is, I don't feel safe. I don't feel 
comfortable asking my colleagues who are my friends, you 
know, to use it. 
C. Norwood: 31:37 So they decided that, you know, that's [inaudible] great in this 
context, you know, if it didn't work it was fatal. Um, and so that 
was the way that you talk. And we did go through, and I made 
one sort of, um, recap for our thought process behind that and 
how they arrived at something that was sort of in a lot of ways, 
counseling and stating recommendations at the time. And so it, 
it, it's very, it's very interesting when you, when you do that. I 
think when you, when you do the access, you reflect with other 
students and you do come to other conclusions and you can 
sort of find those gaps and limitations. And I think that the 
benefit of having diversity on our team, gets at that at least, you 
know, interdisciplinary and the different things. This scenario, 
the diverse group with different backgrounds working 
throughout a topic, you know, entered it where it was sort of 
secondary in the report, but I think it's very important. 
C. Norwood: 32:43 It gets the different perspective and very early, you know, the 
people who are asking to do this thing as well as sort of the 
thought we need all the ones who are giving the guidelines and 
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you know, that was also the thread of why they would even see 
what they will be able to see it because they did a lot of people 
from a lot of different backgrounds. You know, they brought in 
writers, they had talks with that. You know, they had CDC and 
they all worked together to modify this and it was a very time-
sensitive thing. 
C. Norwood: 33:24 And you know, something that they probably would have taken 
many, many months to do. They cranked out this revision 
videos and training, things like that. I think, um definitely I could 
say in two weeks, which is, yeah, that was definitely some 
urgency. And you know, I guess that also goes back not to go 
too long, but I'll go back to the whole thing about, you know, 
not always having all the data. Sometimes you flesh it out as 
well. And that's like that you have, you know, we never really 
have the luxury of having all the answers and there's also that 
thing called, you know, paralysis by analysis. 
C. Norwood: 34:06 And they didn't have that, you know, they didn't have that 
luxury. They relied very heavily on gut feeling. So for this team, 
the data were just one component of their decision making, and 
I think that's very important that [inaudible] medical, you know, 
uncommon time. 
C. Molloy: 34:31 Absolutely. I love that. That the, the strength of the 
interdisciplinary perspectives coming together, that working 
with what they had and this very time sensitive sort of way and 
that in those contexts, relying on something like gut feeling 
becomes really, really important and effective. That's great. The 
last question I have for the two of you is if you could just take it 
individually: what's next for you? What are you up to you? 
What's on the horizon that you're excited about that you want 
listeners to also know about. 
L. Angeli: 35:02 You want to know? My first word is after that question in our 
notes? 
L. Angeli: 35:06 Awesomeness. 
L. Angeli: 35:09 We are what you could expect to see as awesomeness, but 
probably not what you're expecting. I don't know. Christina, do 
you want to go first? 
C. Norwood: 35:16 Oh, well sure. So, you know, I sort of alluded a little bit, you 
know, for the last five or six years may have sort of almost feel 
like looking back, a lot is happening very quickly. Oh, I've had a 
lot of great things happen in my career. And I, you know, I've 
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done a lot of things while working full time. I have two children, 
you know, I'm married. And so for me, and I was talking to Liz 
about this, I think for me, like what I'm looking forward to is just 
like patting myself on the back a little. 
C. Molloy: 35:52 Yeah! 
C. Norwood: 35:53 And just appreciative of where I am and you know, kind of 
soaking that in. And you know, maybe sometime later there'll 
be another project, you know, or something like that. But I, I 
feel like right now I'm in a very good place professionally and it's 
because of all the work that happened before this. So I just 
want to take some time to appreciate that. 
C. Molloy: 36:19 I love that. I love that "pat yourself on the back." Just rest on 
your laurels. Just for a minute. I love that. That's great. 
L. Angeli: 36:27 Cause yeah, we've been doing this, like you said, since 2014, it's 
five years now. And so, you know, and there does come a point I 
think with projects like this where, how much longer can you 
write about it? And you know, before it's sort of, okay, we're 
getting on 10 years now, 15 years. And it's not just that there's 
not value, but if we really wanted to push it or not push it but 
extend it we'd need to start doing more, more case studies. And 
you know, we're, we're in different time zones now or different, 
you know, parts of the country. And that was actually, it was 
great when Christina and I first started talking about this, that 
was one of the first things she said, she's like, let's talk about 
that last question. And I said, okay, I said and when she said, 
you know, I'm, I'm cool with where we're at. 
L. Angeli: 37:10 I said, you know what, yes. And I don't think that's something 
that is shared enough, just satisfied with the work that you've 
done. And just knowing that some research projects have, have 
sort of this, this lifespan. But it was sort of on, on my end in 
terms of, you know, the research that I'm doing. I have, I guess 
three big things. I have two, I think most people know that I 
work with emergency medical services and I'm starting to 
expand to EMS services that also were fire side, or fire services. 
And so I'm learning a lot about fire report writing. And I have 
two pretty big research projects going on with two different 
agencies right now with that. And so, it's, it's, it's my happy 
place. I always say any day I get to spend at a firehouse is an 
excellent day for me. 
C. Molloy: 37:59 So, so cool. Have you met Tim Amidon: yeah, you know him, so 
Tim is so, so amazing. I mean you know, I love your work. I 
mean, I always say, and since I saw you present at CCCCs the 
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first time it remains the best conference presentation like just in 
terms of polish and take away like, you know, you go to some 
that are great and you go to some that are better serviceable 
and that one I was like, that's the best. 
L. Angeli: 38:25 Oh, thank you. That means a lot. Wow. 
C. Molloy: 38:30 I'm a big fan. It was just very polished. I mean there were, 
everything was crystal clear there. If it was probably, it makes a 
lot of sense. And from reading some of your other work and 
talking with you just as a thinker that it was not overly 
academic, it was very like practical but not less rigorous or 
interesting for that. So, yeah, I think that you have a way of 
making the complexity really palatable and, and something that 
lots of different people could benefit from, including in this 
persuasion brief. The two of you did a really nice job. So super 
excited to be doing this and to have done this interview with 
the two of you. So hopefully, you know, keep pushing out and 
getting, making people aware of it and even having it be a really 
great companion piece for people that want to assign it in their 
classes to then be able to hear Christina telling the story, the 
backstory, to hear the explanations of some of these moves that 
you made in your collaboration. Thank you very much. 
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